<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31837826</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0168-9525</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Trends in genetics : TIG</Title><ISOAbbreviation>Trends Genet</ISOAbbreviation></Journal><ArticleTitle>New Roles for Canonical Transcription Factors in Repeat Expansion Diseases.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>92</EndPage><MedlinePgn>81-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tig.2019.11.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-9525(19)30243-4</ELocationID><Abstract><AbstractText>The presence of microsatellite repeat expansions within genes is associated with &gt;30 neurological diseases. Of interest, (GGGGCC)<sub>&gt;30</sub>-repeats within C9orf72 are associated with amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). These expansions can be 100s to 1000s of units long. Thus, it is perplexing how RNA-polymerase II (RNAPII) can successfully transcribe them. Recent investigations focusing on GGGGCC-transcription have identified specific, canonical complexes that may promote RNAPII-transcription at these GC-rich microsatellites: the DSIF complex and PAF1C. These complexes may be important for resolving the unique secondary structures formed by GGGGCC-DNA during transcription. Importantly, this process can produce potentially toxic repeat-containing RNA that can encode potentially toxic peptides, impacting neuron function and health. Understanding how transcription of these repeats occurs has implications for therapeutics in multiple diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Lindsey D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Molecular and Human Genetics, Neurological Research Institute, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonini</LastName><ForeName>Nancy M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: nbonini@sas.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 NS009727</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS078283</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS097275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007517</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Genet</MedlineTA><NlmUniqueID>8507085</NlmUniqueID><ISSNLinking>0168-9525</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D012319">RNA Polymerase II</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020862" MajorTopicYN="N">GC Rich Sequence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018895" MajorTopicYN="N">Microsatellite Repeats</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012319" MajorTopicYN="N">RNA Polymerase II</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS/FTD</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">DSIF complex</Keyword><Keyword MajorTopicYN="N">Drosophila</Keyword><Keyword MajorTopicYN="N">PAF1C</Keyword><Keyword MajorTopicYN="N">transcription</Keyword></KeywordList><CoiStatement>Competing interests. The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31837826</ArticleId><ArticleId IdType="mid">NIHMS1543289</ArticleId><ArticleId IdType="pmc">PMC6980727</ArticleId><ArticleId IdType="doi">10.1016/j.tig.2019.11.003</ArticleId><ArticleId IdType="pii">S0168-9525(19)30243-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Banez-Coronel M and Ranum LPW (2019) Repeat-associated non-AUG (RAN) translation: insights from pathology. Laboratory Investigation 99, 929&#x2013;942</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219275</ArticleId><ArticleId IdType="pubmed">30918326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C and Petrucelli L (2019) Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron 101, 1057&#x2013;1069</Citation><ArticleIdList><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochman ML et al. (2012) DNA secondary structures: stability and function of G-quadruplex structures. Nature Reviews Genetics 13, 770&#x2013;780</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3725559</ArticleId><ArticleId IdType="pubmed">23032257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik M et al. (2016) A bouquet of DNA structures: Emerging diversity. Biochemistry and Biophysics Reports 5, 388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5600441</ArticleId><ArticleId IdType="pubmed">28955846</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G and Piccininni M (2019) Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference. NED 52, 93&#x2013;103</Citation><ArticleIdList><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>Seltman RE and Matthews BR (2012) Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management. CNS Drugs 26, 841&#x2013;870</Citation><ArticleIdList><ArticleId IdType="pubmed">22950490</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M et al. (2006) Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science 314, 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagi KS et al. (2019) Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis. Neuroscience 396, A3&#x2013;A20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6549511</ArticleId><ArticleId IdType="pubmed">30594291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C et al. (2019) Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol DOI: 10.1007/s00401-019-01962-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01962-9</ArticleId><ArticleId IdType="pmc">PMC6533145</ArticleId><ArticleId IdType="pubmed">30739198</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M et al. (2014) Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging 35, 2421.e13&#x2013;2421.e17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105839</ArticleId><ArticleId IdType="pubmed">24866401</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M et al. (2014) TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol 127, 397&#x2013;406</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944829</ArticleId><ArticleId IdType="pubmed">24385136</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S et al. (2019) Genetics of amyotrophic lateral sclerosis: A review. Journal of the Neurological Sciences 399, 217&#x2013;226</Citation><ArticleIdList><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C et al. (2016) Genetics of FTLD: overview and what else we can expect from genetic studies. J. Neurochem 138, 32&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">27009575</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M et al. (2011) Expanded GGGGCC hexanucleotide repeat in non-coding region of C9ORF72 causes chromosome 9p-linked frontotemporal dementia and amyotrophic lateral sclerosis. Neuron 72, 245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng ASL and Tan E-K (2017) Intermediate C9orf72 alleles in neurological disorders: does size really matter? Journal of Medical Genetics 54, 591&#x2013;597</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5574395</ArticleId><ArticleId IdType="pubmed">28689190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourinaris T and Houlden H (2018) C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature. Movement Disorders Clinical Practice 5, 575&#x2013;585</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277362</ArticleId><ArticleId IdType="pubmed">30637277</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD et al. (2019) Expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat Neurosci</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6535128</ArticleId><ArticleId IdType="pubmed">31110321</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y et al. (2016) C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron 90, 521&#x2013;534</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R and Isaacs AM (2018) C9orf72 -mediated ALS and FTD: multiple pathways to disease. Nature Reviews Neurology 14, 544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC et al. (2019) C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol 137, 1&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD and Bonini NM (2019) Repeat-associated non-AUG (RAN) translation mechanisms running into focus for GGGGCC-repeat associated ALS/FTD. Prog. Neurobiol DOI: 10.1016/j.pneurobio.2019.101697</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.101697</ArticleId><ArticleId IdType="pmc">PMC6941355</ArticleId><ArticleId IdType="pubmed">31550516</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S et al. (2018) Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol 135, 459&#x2013;474</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakae N et al. (2018) Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathologica Communications 6, 63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6054740</ArticleId><ArticleId IdType="pubmed">30029693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA et al. (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77, 639&#x2013;646</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z-F et al. (2019) The Hairpin Form of r(G4C2)exp in c9ALS/FTD Is Repeat-Associated Non-ATG Translated and a Target for Bioactive Small Molecules. Cell Chemical Biology 26, 179&#x2013;190.e12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386614</ArticleId><ArticleId IdType="pubmed">30503283</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR et al. (2014) C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease. Nature 507, 195&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;ket P et al. (2015) Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neurobiology of Aging 36, 1091&#x2013;1096</Citation><ArticleIdList><ArticleId IdType="pubmed">25442110</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B et al. (2015) Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD. Scientific Reports 5,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643247</ArticleId><ArticleId IdType="pubmed">26564809</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J and Plavec J (2017) ALS and FTD linked GGGGCC-repeat containing DNA oligonucleotide folds into two distinct G-quadruplexes. Biochimica et Biophysica Acta (BBA) - General Subjects 1861, 1237&#x2013;1245</Citation><ArticleIdList><ArticleId IdType="pubmed">27856299</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P et al. (2012) C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci Rep 2,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K et al. (2013) The Disease-associated r(GGGGCC)n Repeat from the C9orf72 Gene Forms Tract Length-dependent Uni- and Multimolecular RNA G-quadruplex Structures. J Biol Chem 288, 9860&#x2013;9866</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z et al. (2014) Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS. Neuron 83, 1043&#x2013;1050</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232217</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K et al. (2014) Processing of double-R-loops in (CAG)&#xb7;(CTG) and C9orf72 (GGGGCC)&#xb7;(GGCCCC) repeats causes instability. Nucleic Acids Res 42, 10473&#x2013;10487</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176329</ArticleId><ArticleId IdType="pubmed">25147206</ArticleId></ArticleIdList></Reference><Reference><Citation>Diab MA et al. (2018) The G-rich Repeats in FMR1 and C9orf72 Loci Are Hotspots for Local Unpairing of DNA. Genetics 210, 1239&#x2013;1252</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6283162</ArticleId><ArticleId IdType="pubmed">30396881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B et al. (2015) Quadruplex formation by both G-rich and C-rich DNA strands of the C9orf72 (GGGGCC)8&#x2022;(GGCCCC)8 repeat: effect of CpG methylation. Nucleic Acids Res 43, 10055&#x2013;10064</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4787773</ArticleId><ArticleId IdType="pubmed">26432832</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B et al. (2018) Stress-induced acidification may contribute to formation of unusual structures in C9orf72 -repeats. Biochimica et Biophysica Acta (BBA) - General Subjects 1862, 14821491</Citation><ArticleIdList><ArticleId IdType="pubmed">29550431</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y et al. (2017) Structure and Dynamics of DNA and RNA Double Helices Obtained from the GGGGCC and CCCCGG Hexanucleotide Repeats That Are the Hallmark of C9FTD/ALS Diseases. ACS Chem. Neurosci 8, 578&#x2013;591</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423440</ArticleId><ArticleId IdType="pubmed">27933757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F et al. (2018) E-motif formed by extrahelical cytosine bases in DNA homoduplexes of trinucleotide and hexanucleotide repeats. Nucleic Acids Res 46, 942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5778509</ArticleId><ArticleId IdType="pubmed">29190385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd DW et al. (2016) Pathogenic C9ORF72 Antisense Repeat RNA Forms a Double Helix with Tandem C:C Mismatches. Biochemistry 55, 1283&#x2013;1286</Citation><ArticleIdList><ArticleId IdType="pubmed">26878348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer PO (2016) Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells. Neuroscience Letters 612, 204&#x2013;209</Citation><ArticleIdList><ArticleId IdType="pubmed">26690922</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z et al. (2015) The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 129, 715&#x2013;727</Citation><ArticleIdList><ArticleId IdType="pubmed">25716178</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R et al. (2017) A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD. Molecular Neurodegeneration 12, 46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468954</ArticleId><ArticleId IdType="pubmed">28606110</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R et al. (2018) G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Mol Med 10, 22&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonkers I and Lis JT (2015) Getting up to speed with transcription elongation by RNA polymerase II. Nat Rev Mol Cell Biol 16, 167&#x2013;177</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782187</ArticleId><ArticleId IdType="pubmed">25693130</ArticleId></ArticleIdList></Reference><Reference><Citation>Duquette ML et al. (2004) Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev 18, 1618&#x2013;1629</Citation><ArticleIdList><ArticleId IdType="pmc">PMC443523</ArticleId><ArticleId IdType="pubmed">15231739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C et al. (2013) DNA G-quadruplex formation in response to remote downstream transcription activity: long-range sensing and signal transducing in DNA double helix. Nucleic Acids Res 41, 7144&#x2013;7152</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3737545</ArticleId><ArticleId IdType="pubmed">23716646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng K et al. (2013) Co-transcriptional formation of DNA:RNA hybrid G-quadruplex and potential function as constitutional cis element for transcription control. Nucleic Acids Res 41, 5533&#x2013;5541</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664831</ArticleId><ArticleId IdType="pubmed">23585281</ArticleId></ArticleIdList></Reference><Reference><Citation>Armas P et al. (2016) Transcriptional control by G-quadruplexes: In vivo roles and perspectives for specific intervention. Transcription 8, 21&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5279714</ArticleId><ArticleId IdType="pubmed">27696937</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe1;zda V et al. (2014) DNA and RNA Quadruplex-Binding Proteins. International Journal of Molecular Sciences 15, 17493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227175</ArticleId><ArticleId IdType="pubmed">25268620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza O et al. (2016) G-quadruplexes and helicases. Nucleic Acids Res 44, 1989&#x2013;2006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4797304</ArticleId><ArticleId IdType="pubmed">26883636</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonkers I et al. (2014) Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons. eLife 3,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001325</ArticleId><ArticleId IdType="pubmed">24843027</ArticleId></ArticleIdList></Reference><Reference><Citation>Veloso A et al. (2014) Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications. Genome Research 24, 896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4032854</ArticleId><ArticleId IdType="pubmed">24714810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam EYN et al. (2013) G-quadruplex structures are stable and detectable in human genomic DNA. Nature Communications 4, 1796</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3736099</ArticleId><ArticleId IdType="pubmed">23653208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers VS et al. (2015) High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nature Biotechnology 33, 877</Citation><ArticleIdList><ArticleId IdType="pubmed">26192317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlicki AS (2016) G-Quadruplexes Involving Both Strands of Genomic DNA Are Highly Abundant and Colocalize with Functional Sites in the Human Genome. PLoS ONE 11,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699641</ArticleId><ArticleId IdType="pubmed">26727593</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks TA and Hurley LH (2010) Targeting MYC Expression through G-Quadruplexes. Genes Cancer 1, 641&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992328</ArticleId><ArticleId IdType="pubmed">21113409</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcel V et al. (2011) G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. Carcinogenesis 32, 271&#x2013;278</Citation><ArticleIdList><ArticleId IdType="pubmed">21112961</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma SP and Das P (2018) G-quadruplex structure at intron 2 of TFE3 and its role in Xp11.2 translocation and splicing. Biochim Biophys Acta Gen Subj. 1862, 630&#x2013;636</Citation><ArticleIdList><ArticleId IdType="pubmed">29138008</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold WC et al. (2010) Exon array analyses across the NCI-60 reveals potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron. Cancer Res 70, 2191&#x2013;2203</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922994</ArticleId><ArticleId IdType="pubmed">20215517</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossley MP et al. (2019) R-Loops as Cellular Regulators and Genomic Threats. Molecular Cell 73, 398&#x2013;411</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402819</ArticleId><ArticleId IdType="pubmed">30735654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N and Jinks-Robertson S (2012) Transcription as a source of genome instability. Nat Rev Genet 13, 204&#x2013;214</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376450</ArticleId><ArticleId IdType="pubmed">22330764</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas P and Aguilera A (2003) Cotranscriptionally Formed DNA:RNA Hybrids Mediate Transcription Elongation Impairment and Transcription-Associated Recombination. Molecular Cell 12, 711&#x2013;721</Citation><ArticleIdList><ArticleId IdType="pubmed">14527416</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;guez-S&#xe1;nchez MS et al. (2011) Genome Instability and Transcription Elongation Impairment in Human Cells Depleted of THO/TREX. PLOS Genetics 7, e1002386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228816</ArticleId><ArticleId IdType="pubmed">22144908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X et al. (2017) Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis. Nature Communications 8,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490191</ArticleId><ArticleId IdType="pubmed">28649985</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivji MKK et al. (2018) BRCA2 Regulates Transcription Elongation by RNA Polymerase II to Prevent R-Loop Accumulation. Cell Reports 22, 1031&#x2013;1039</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846855</ArticleId><ArticleId IdType="pubmed">29386125</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C et al. (2018) Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters. Molecular Cell 69, 426&#x2013;437.e7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815878</ArticleId><ArticleId IdType="pubmed">29395064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ et al. (2016) Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts associated with c9FTD/ALS. Science 353, 708&#x2013;712</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartzog GA and Fu J (2013) The Spt4-Spt5 complex: a multi-faceted regulator of transcription elongation. Biochimica et biophysica acta 1829, 105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545043</ArticleId><ArticleId IdType="pubmed">22982195</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-R et al. (2012) Spt4 Is Selectively Required for Transcription of Extended Trinucleotide Repeats. Cell 148, 690&#x2013;701</Citation><ArticleIdList><ArticleId IdType="pubmed">22341442</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H-M et al. (2015) Effects on Murine Behavior and Lifespan of Selectively Decreasing Expression of Mutant Huntingtin Allele by Supt4h Knockdown. PLoS Genet 11,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356588</ArticleId><ArticleId IdType="pubmed">25760041</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta N et al. (2019) Suppression of the yeast elongation factor Spt4 ortholog reduces expanded SCA36 GGCCUG repeat aggregation and cytotoxicity. Brain Research DOI: 10.1016/j.brainres.2018.12.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.045</ArticleId><ArticleId IdType="pubmed">30610877</ArticleId></ArticleIdList></Reference><Reference><Citation>Naguib A et al. (2019) SUPT4H1 Depletion Leads to a Global Reduction in RNA. Cell Reports 26, 45&#x2013;53.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">30605685</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oss SB et al. (2017) Emerging Insights into the Roles of the Paf1 Complex in Gene Regulation. Trends in Biochemical Sciences 42, 788&#x2013;798</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5658044</ArticleId><ArticleId IdType="pubmed">28870425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu B et al. (2005) The human PAF complex coordinates transcription with events downstream of RNA synthesis. Genes Dev. 19, 1668&#x2013;1673</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1176003</ArticleId><ArticleId IdType="pubmed">16024656</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman K et al. (2006) Drosophila Paf1 Modulates Chromatin Structure at Actively Transcribed Genes. Mol Cell Biol 26, 250&#x2013;260</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1317635</ArticleId><ArticleId IdType="pubmed">16354696</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbogning J et al. (2013) The PAF Complex and Prf1/Rtf1 Delineate Distinct Cdk9-Dependent Pathways Regulating Transcription Elongation in Fission Yeast. PLoS Genet 9,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3873232</ArticleId><ArticleId IdType="pubmed">24385927</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q-F et al. (2015) Characterization of the Human Transcription Elongation Factor Rtf1: Evidence for Nonoverlapping Functions of Rtf1 and the Paf1 Complex. Mol Cell Biol 35, 3459&#x2013;3470</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4573716</ArticleId><ArticleId IdType="pubmed">26217014</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermody JL and Buratowski S (2010) Leo1 Subunit of the Yeast Paf1 Complex Binds RNA and Contributes to Complex Recruitment. J. Biol. Chem 285, 33671&#x2013;33679</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2962465</ArticleId><ArticleId IdType="pubmed">20732871</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrich CG et al. (2012) Cdc73 Subunit of Paf1 Complex Contains C-terminal Ras-like Domain That Promotes Association of Paf1 Complex with Chromatin. J Biol Chem 287, 10863&#x2013;10875</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322841</ArticleId><ArticleId IdType="pubmed">22318720</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H et al. (2012) Pol II CTD kinases Bur1 and Kin28 promote Spt5 CTR-independent recruitment of Paf1 complex. EMBO J 31, 3494&#x2013;3505</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3419927</ArticleId><ArticleId IdType="pubmed">22796944</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y et al. (2018) Paf1 and Ctr9 subcomplex formation is essential for Paf1 complex assembly and functional regulation. Nature Communications 9,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6143631</ArticleId><ArticleId IdType="pubmed">30228257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TS et al. (2010) RNA polymerase mapping during stress responses reveals widespread nonproductive transcription in yeast. Genome Biology 11, R75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2926786</ArticleId><ArticleId IdType="pubmed">20637075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu X et al. (2013) Structural insights into Paf1 complex assembly and histone binding. Nucleic Acids Res 41, 10619&#x2013;10629</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3905892</ArticleId><ArticleId IdType="pubmed">24038468</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y et al. (2017) Architecture of the RNA polymerase II-Paf1C-TFIIS transcription elongation complex. Nature Communications 8, 15741</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467213</ArticleId><ArticleId IdType="pubmed">28585565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos SM et al. (2018) Structure of paused transcription complex Pol II&#x2013;DSIF&#x2013;NELF. Nature 560, 601&#x2013;606</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6245578</ArticleId><ArticleId IdType="pubmed">30135580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rond&#xf3;n AG et al. (2003) Molecular evidence for a positive role of Spt4 in transcription elongation. The EMBO Journal 22, 612&#x2013;620</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140732</ArticleId><ArticleId IdType="pubmed">12554661</ArticleId></ArticleIdList></Reference><Reference><Citation>Rond&#xf3;n AG et al. (2004) Molecular evidence indicating that the yeast PAF complex is required for transcription elongation. EMBO Rep 5, 47&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1298956</ArticleId><ArticleId IdType="pubmed">14710186</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos SM et al. (2018) Structure of activated transcription complex Pol II&#x2013;DSIF&#x2013;PAF&#x2013;SPT6. Nature 560, 607&#x2013;612</Citation><ArticleIdList><ArticleId IdType="pubmed">30135578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y et al. (2009) DSIF, the Paf1 complex, and Tat-SF1 have nonredundant, cooperative roles in RNA polymerase II elongation. Genes Dev. 23, 2765&#x2013;2777</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2788331</ArticleId><ArticleId IdType="pubmed">19952111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer A et al. (2010) Uniform transitions of the general RNA polymerase II transcription complex. Nature Structural &amp; Molecular Biology 17, 1272</Citation><ArticleIdList><ArticleId IdType="pubmed">20818391</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oss SB et al. (2016) The Histone Modification Domain of Paf1 Complex Subunit Rtf1 Directly Stimulates H2B Ubiquitylation Through an Interaction with Rad6. Mol Cell 64, 815&#x2013;825</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131541</ArticleId><ArticleId IdType="pubmed">27840029</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M et al. (2017) Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum Mol Genet 26, 3421&#x2013;3431</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs-Disney JL et al. (2014) Structure of the Myotonic Dystrophy Type 2 RNA and Designed Small Molecules That Reduce Toxicity. ACS chemical biology 9, 538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944380</ArticleId><ArticleId IdType="pubmed">24341895</ArticleId></ArticleIdList></Reference><Reference><Citation>van Cruchten RTP et al. (2019) Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences. RNA 25, 481&#x2013;495</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6426290</ArticleId><ArticleId IdType="pubmed">30700578</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyzosiak WJ et al. (2012) Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res 40, 11&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245940</ArticleId><ArticleId IdType="pubmed">21908410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari D et al. (2011) Repeat Expansion Affects Both Transcription Initiation and Elongation in Friedreich Ataxia Cells. J Biol Chem 286, 4209&#x2013;4215</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039332</ArticleId><ArticleId IdType="pubmed">21127046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y and Wilson JH (2011) Transcription-induced DNA toxicity at trinucleotide repeats. Cell Cycle 10, 611&#x2013;618</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173998</ArticleId><ArticleId IdType="pubmed">21293182</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IX et al. (2018) Human proteins that interact with RNA/DNA hybrids. Genome Res. 28, 1405&#x2013;1414</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120628</ArticleId><ArticleId IdType="pubmed">30108179</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahba L et al. (2011) RNase H and Multiple RNA Biogenesis Factors Cooperate to Prevent RNA:DNA Hybrids from Generating Genome Instability. Molecular Cell 44, 978&#x2013;988</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3271842</ArticleId><ArticleId IdType="pubmed">22195970</ArticleId></ArticleIdList></Reference><Reference><Citation>Landsverk HB et al. (2019) Regulation of ATR activity via the RNA polymerase II associated factors CDC73 and PNUTS-PP1. Nucleic Acids Res 47, 1797&#x2013;1813</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393312</ArticleId><ArticleId IdType="pubmed">30541148</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidle S (2010) Human telomeric G-quadruplex: The current status of telomeric G-quadruplexes as therapeutic targets in human cancer. The FEBS Journal 277, 1118&#x2013;1125</Citation><ArticleIdList><ArticleId IdType="pubmed">19951354</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues J and Lydall D (2018) Paf1 and Ctr9, core components of the PAF1 complex, maintain low levels of telomeric repeat containing RNA. Nucleic Acids Res 46, 621&#x2013;634</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5778495</ArticleId><ArticleId IdType="pubmed">29145644</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana S and Selig S (2018) DNA:RNA hybrids at telomeres &#x2013; when it is better to be out of the (R) loop. The FEBS Journal 285, 2552&#x2013;2566</Citation><ArticleIdList><ArticleId IdType="pubmed">29637701</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi X et al. (2015) Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer. Biochemical and Biophysical Research Communications 465, 685&#x2013;690</Citation><ArticleIdList><ArticleId IdType="pubmed">26282204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach JM et al. (2017) PAF1 complex component Leo1 helps recruit Drosophila Myc to promoters. PNAS 114, E9224&#x2013;E9232</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5676885</ArticleId><ArticleId IdType="pubmed">29078288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer M and Paeschke K (2017) G-quadruplex unwinding helicases and their function in vivo. Biochemical Society Transactions 45, 1173&#x2013;1182</Citation><ArticleIdList><ArticleId IdType="pubmed">28939694</ArticleId></ArticleIdList></Reference><Reference><Citation>Erwin GS et al. (2017) Synthetic transcription elongation factors license transcription across repressive chromatin. Science 358, 1617&#x2013;1622</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6037176</ArticleId><ArticleId IdType="pubmed">29192133</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL and Miller TM (2013) Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA. Neurotherapeutics 10, 486&#x2013;497</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701770</ArticleId><ArticleId IdType="pubmed">23686823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoch KM and Miller TM (2017) Antisense oligonucleotides: Translation from mouse models to human neurodegenerative diseases. Neuron 94, 1056&#x2013;1070</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5821515</ArticleId><ArticleId IdType="pubmed">28641106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi HY (2019) Strategy to selectively remove mutant proteins could combat neurodegeneration. Nature 575, 57&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">31690850</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>